Quotient Wealth Partners’s Biogen BIIB Stock Holding History
Bought
Maintained
Sold
Other funds holding BIIB
VCM
VPM
Quotient Wealth Partners's BIIB Position: Q1 2026 in Review
Quotient Wealth Partners opened a new position in Biogen (BIIB) in Q1 2026: 1,097 shares worth $201K. The stake represents 0.01% of the portfolio and ranks #360 among its holdings. This is a return to the name: Quotient Wealth Partners previously reported a position in BIIB as recently as Q3 2024.
Quotient Wealth Partners first reported a position in BIIB in Q4 2023 and has held it in 5 quarters since. The position peaked at $3.45M in Q4 2023. 1,002 funds tracked by Wall St. Rank hold BIIB as of Q1 2026.
- Quotient Wealth Partners held 1,097 shares of Biogen worth $201K as of Q1 2026.
- Biogen was a new Quotient Wealth Partners position in Q1 2026.
- Biogen made up 0.01% of Quotient Wealth Partners's portfolio in Q1 2026, its #360 holding.
- Quotient Wealth Partners first reported a position in Biogen in Q4 2023 and has held it in 5 quarters since.
- Quotient Wealth Partners's Biogen position peaked at $3.45M in Q4 2023.
- 1,002 funds tracked by Wall St. Rank held Biogen as of Q1 2026.
Based on Quotient Wealth Partners's 13F filing for Q1 2026, filed 16 Apr 2026.